经前纵裂入路显微手术切除鞍结节脑膜瘤的疗效观察及安全性评估(附19例报告)  

The Curative Effect Observation and Safety Evaluation of Microsurgical Removal of Tuberculum Sellae Meningiomas through Anterior Interhemispheric Approach( A 19 Cases Report)

作　　者：张建国[1] 零达尚[1] 张晓峰[1] 

机构地区：[1]南方医科大学附属小榄医院神经外科,广东中山528415

出　　处：《医学综述》2014年第1期168-170,共3页Medical Recapitulate

摘　　要：目的 探讨经前纵裂入路显微手术切除鞍结节脑膜瘤（TSM）的临床疗效,并评估其安全性.方法 回顾性分析2007年2月至2012年8月期间在南方医科大学附属小榄医院神经外科治疗的19例TSM患者采用经前纵裂入路显微手术切除的临床资料.结果 19例患者均成功完成手术,Simpson Ⅰ级和Ⅱ级切除18例（94.7%）,无死亡病例出现.术后对所有患者随访3 ~20个月,均未出现复发,3个月时14例患者的视力有不同程度好转,5例视力无好转,11例视野缺损较术前改善.术后出现尿崩症2例,额叶静脉性梗死1例,发热1例.结论 经前纵裂入路显微手术切除TSM全切率高,预后良好,安全有效,可作为TSM优选的手术方式.Objective To investigate the clinical effect of microsurgical removal of tuberculum sellae meningiomas（ TSM ）through anterior interhemispheric approach, and evaluate its safety. Methods Retro- spective analysis on the clinical data of 19 patients with TSM treated by microsurgery through anterior inter- hemispheric approach in Department of Neurosurgery, Xiaolan Affiliated Hospital of Southern Medical Univer- sity from Feb. 2007 to Aug. 2012 was done. Results All of the 19 patients successfully completed the opera- tion, resection （Simpson I, II ）was achieved in 18 patients （94.7 % ）, no deaths. All patients were followed up for 3-20 months, there was no recurrence, at 3 months, 14 patients had an improvement of the visual acuity in varying degrees, 5 patients showed no improvement, 11 patients with visual field defect improved than before. Diabetes insipidus occurred in 2 cases after operation, frontal lobe venous infarction occurred in one patient, one patient had fever. Conclusion The resection rate of microsurgical removal of TSM through ante- rior interhemispheric approach is high, and its prognosis is goocl, safe and effective, which can be used as the preferred way of TSM operation.

关 键 词：前纵裂入路 显微 鞍结节脑膜瘤 

分 类 号：R739.45[医药卫生—肿瘤]